SCHEMBL29700425

SCHEMBL29700425

O=C(NC1CC2(C1)CC(c1nc3cc(Cl)ccc3s1)C2)C1CCS(=O)(=O)C1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ CNR2 P34972 3/20 0.39
▸ ALDH1A1 P00352 3/20 0.36
▸ CASP3 P42574 1/20 0.36
▸ SENP8 Q96LD8 1/20 0.36
▸ SENP7 Q9BQF6 1/20 0.36
▸ SENP6 Q9GZR1 1/20 0.36
▸ POLB P06746 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ PTGES O14684 4/20 0.35
▸ PTGS2 P35354 1/20 0.35
▸ LMNA P02545 3/20 0.35
▸ CNR1 P21554 1/20 0.35
▸ ROCK2 O75116 2/20 0.34
▸ MAPT P10636 2/20 0.33
▸ HTT P42858 1/20 0.33
▸ HCRTR1 O43613 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26185602 1.00 NPC1 (0.43) NPC1RAB9ACNR2ALDH1A1CASP3
SCHEMBL26185589 0.93 CASP3 (0.44) NPC1RAB9ACNR2ALDH1A1CASP3
SCHEMBL29700519 0.93 NPC1 (0.43) NPC1RAB9ACNR2CASP3SENP8
SCHEMBL26185604 0.93 NPC1 (0.43) NPC1RAB9ACNR2CASP3SENP8
SCHEMBL26567756 0.89 DYRK1A (0.36) NPC1RAB9AALDH1A1LMNAROCK2
SCHEMBL24478819 0.89 NPC1 (0.48) NPC1RAB9ACNR2ALDH1A1CASP3
SCHEMBL29700396 0.83 NPC1 (0.44) NPC1RAB9ACNR2CASP3SENP8
SCHEMBL26185581 0.83 NPC1 (0.44) NPC1RAB9ACNR2CASP3SENP8
SCHEMBL29700392 0.82 NPC1 (0.40) NPC1RAB9ACNR2ALDH1A1POLB
SCHEMBL26185597 0.82 NPC1 (0.40) NPC1RAB9ACNR2ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4251615-B1 SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION HOFFMANN LA ROCHE (CH) 2025-10-15 — — EP claimed
EP-4251615-A1 SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2023-10-04 — — EP claimed
WO-2022112188-A1 SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2022-06-02 — — WO claimed
EP-4251615-A1 SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2023-10-04 — — EP disclosed
WO-2022112188-A1 SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2022-06-02 — — WO disclosed
Send feedback